Fleury

C₂N Diagnostics Partners with Grupo Fleury to Bring Pioneering Blood Tests to Brazil for Advancing Brain Health

Retrieved on: 
Wednesday, September 21, 2022
Medical Supplies, Biotechnology, Other Health, Health, General Health, Neurology, Mental Health, Other Science, Medical Devices, Research, Science, Reproduction, Center for Epidemiologic Studies Depression Scale, ASX, Neurodegeneration, Precision medicine, Memory, Marie Cassidy, Child care, Efficiency, Saliva, Disease, Entrepreneurship, City, Biomarker, Blood, Acquisition, Health, Partnership, SP, Diagnosis, HLS, Fleury, Davos, Patient, History, Physician, CEO, Standard of care, Pathology, Awareness, Plasma, Alzheimer's disease, Lists of diseases, Medical imaging, Medical device, Pharmaceutical industry, C2N

C2N Diagnostics , a leader in advanced brain health diagnostics, today announced it has entered a partnership with Grupo Fleury (BVMF: FLRY), one of Brazils leading healthcare companies, to bring blood-based tests that aid in early Alzheimers diagnosis to patient care in Brazil.

Key Points: 
  • C2N Diagnostics , a leader in advanced brain health diagnostics, today announced it has entered a partnership with Grupo Fleury (BVMF: FLRY), one of Brazils leading healthcare companies, to bring blood-based tests that aid in early Alzheimers diagnosis to patient care in Brazil.
  • Data from the Brazilian Ministry of Health estimate that there are 1.2 million cases of Alzheimer's disease in Brazil, most of them without an established diagnosis.
  • Grupo Fleury is a premier organization with an established history of providing high-quality healthcare services to patients throughout Brazil, including diagnostic and precision medicine.
  • C2N Diagnostics is a leader in advanced brain health diagnostics with a vision to bring Clarity Through Innovation.

Condor Technologies to Reopen Trading on the Euronext Exchange in Paris

Retrieved on: 
Monday, August 22, 2022
Electronic Design Automation, Health, Medical Devices, Technology, Practice Management, Other Technology, Dental, CEO, 3D, SAS, CAD, IDS, Fleury, CAD CAM, Dentist, Television, Dentistry

We are pleased to announce the reopening of the trading sessions on August 23rd for Condor Technologies (MLMFI.PA) on the Euronext Access Exchange in Paris.

Key Points: 
  • We are pleased to announce the reopening of the trading sessions on August 23rd for Condor Technologies (MLMFI.PA) on the Euronext Access Exchange in Paris.
  • The resumption of the trading coincides with the last phase of the development of our second generation intra oral scanner.
  • Invisart is a French company 99,99 % owned by Condor Technologies.
  • Condor Technologies is a company specialized in dental CAD/CAM equipment, with its most known product the Invisart Tray Scanner.

Canadian securities regulators to host roundtable on the proposed Derivatives Business Conduct Rule

Retrieved on: 
Friday, August 12, 2022
Ontario Teachers' Pension Plan, Associate, Ontario Securities Commission, OTC, CSA, Canadian Securities Administrators, Business transformation, Fleury, National bank, Compliance, National Bank of Canada, Audit

TORONTO, Aug. 12, 2022 /CNW/ - The Canadian Securities Administrators (CSA) today announced it will host a virtual roundtable on the proposed derivatives business conduct rule, the CSA's next step towards modernizing the regulatory framework for the OTC derivatives market in Canada.

Key Points: 
  • TORONTO, Aug. 12, 2022 /CNW/ - The Canadian Securities Administrators (CSA) today announced it will host a virtual roundtable on the proposed derivatives business conduct rule, the CSA's next step towards modernizing the regulatory framework for the OTC derivatives market in Canada.
  • The roundtable will be held on September 28, 2022 from 10:00 a.m. 12:00 p.m.
  • Expert panels will explore a number of regulatory, implementation and compliance issues related to the CSA's plan to adopt a final rule in the upcoming year.
  • The CSA, the council of the securities regulators of Canada's provinces and territories, co-ordinates and harmonizes regulation for the Canadian capital markets.

Grupo Fleury Streamlines Demand Planning with FICO Platform

Retrieved on: 
Thursday, March 28, 2019
Articles, Business, Technology, Supply chain management, Credit scoring, FICO, Forecasting, Fleury, Xpress, Artificial intelligence

Grupo Fleury, one of Brazil's largest diagnostic medical companies, worked with FICO to create a demand planning management tool, known as the Fleury Forecaster

Key Points: 
  • Grupo Fleury, one of Brazil's largest diagnostic medical companies, worked with FICO to create a demand planning management tool, known as the Fleury Forecaster
    The company's sales forecasts have increased in accuracy, showing an overall mean absolute percentage error (MAPE) of less than 10 percent
    Grupo Fleury has been recognized in the AI, Machine Learning & Optimization category at the 2018 FICO Decisions Awards
    Grupo Fleury, one of Brazil's largest diagnostic medicine companies, has created an automated demand planning management platform the Fleury Forecaster with the help of FICO Xpress Insight.
  • For its achievements, Grupo Fleury has been recognized in the AI, Machine Learning & Optimization category in the 2018 FICO Decisions Awards.
  • Grupo Fleury manages a robust demand planning process in order to appropriately allocate its 10,000+ employees at the necessary locations for the appropriate amount of time.
  • The Fleury Forecaster can show both real-time levels of demand and continuously updated demand forecasts across Grupo Fleury's extensive medical services portfolio.